On 24 September 2008, the Organisation for Economic Co-operation and Development (OECD) released a new Report on Pharmaceutical Pricing Policies in a Global Market.
This report assesses how pharmaceutical pricing and reimbursement policies have contributed to the achievement of certain health policy objectives. It examines the national and transnational effects of these policies, in particular, their implications for the availability of medicines in other countries, the prices of these medicines, and innovation in the pharmaceutical sector.
This publication presents an analysis of comparative price levels, making use of a unique dataset to construct the most comprehensive pan-OECD pharmaceutical price index to date. It also draws upon original case studies of pharmaceutical pricing and reimbursement policies in six OECD countries to provide specific examples of the impacts of policies on health system performance.
For further information
Read the complete executive summary
Only subscribers and readers at subscribing institutions can access the online edition via SourceOECD, the online library. Non-subscribers can purchase the PDF e-book and/or paper copy via the Online Bookshop.
EPHA related articles
OECD guidelines on work/family life balance
OECD calls for employment strategies to include social goals
